Portrait of Tina Gupta

Tina Gupta

Assistant Professor
Psychology
Phone: 541-346-4162
Research Interests: Clinical Psychology, Adolescent Development, Risk for Severe Mental Illness, Psychosis-risk, Resilience, Emotion, Negative Symptoms, Reward Processing, Early Intervention and Prevention, Affective Neuroscience

Biography

Dr. Gupta is an Assistant Professor of Clinical Psychology and directs the Changes in Adolescent Risk and Emotions (CARE) Lab. She received her PhD in clinical psychology from Northwestern University, completed her clinical internship at Western Psychiatric Institute and Clinic/University of Pittsburgh Medical Center, and completed her postdoctoral training at the University of Pittsburgh School of Medicine. Her research examines how emotional processes develop, and how they become disrupted, in youth at risk for severe mental illness (SMI), including those at clinical high risk for psychosis. Adolescence brings rapid change across the brain, body, and social world, making it a time of great potential but also a window when early signs of SMI, such as persistent loss of interest or unusual perceptual experiences, often first emerge. Dr. Gupta’s work examines how brain development, pubertal maturation, relationships, and early life experiences shape risk for negative symptoms such as anhedonia, and seeks to identify protective factors and mechanism-based targets for prevention and early intervention. Her lab takes a multi-method approach, combining clinical interviews, behavioral tasks, ecological momentary assessment, neuroimaging, hormonal and immune markers, and computational modeling. Ultimately, her goal is to understand how, why, and for whom vulnerability emerges during adolescence, so that young people have the best chance to thrive.

Dr. Gupta is not accepting a doctoral student for Fall 2027.

Selected Publications (see full listing at Google Scholar):

Konstas, K., & Gupta, T. (2026). Blunted affect in schizophrenia. Schizophrenia Research, 293, 32-38. 

Gupta, T., Seah, T.H.S., Eckstrand, K.L., Rengasamy, M., Horter, C., Silk, J.S., Jones, N.P., Ryan, N.D., Phillips, M.L., Haas, G.L., Nance, M., Lindenmuth, M., Forbes, E.E (2024). Two-year trajectories of anhedonia in adolescents at transdiagnostic risk for severe mental illness: Association with clinical symptoms and brain-symptom links.  Journal of Psychopathology and Clinical Science, 133(8), 618.

Gupta, T., Eckstrand, K. L., Lenniger, C. J., Haas, G. L., Silk, J. S., Ryan, N. D., ... & Forbes, E. E. (2024). Anhedonia in adolescents at transdiagnostic familial risk for severe mental illness: Clustering by symptoms and mechanisms of association with behavior. Journal of Affective Disorders, 347, 249-261.

Gupta, T., Eckstrand, K. L., & Forbes, E. E. (2024). Annual Research Review: Puberty and the development of anhedonia–considering childhood adversity and inflammation. Journal of Child Psychology and Psychiatry, 65(4), 459-480.

Gupta, T., Antezana, L., Porter, C., Mayanil, T., Bylsma, L. M., Maslar, M., & Horton, L. E. (2023). Skills program for awareness, connectedness, and empowerment: A conceptual framework of a skills group for individuals with a psychosis-risk syndrome. Frontiers in Psychiatry, 14, 1083368.

Gupta, T., Osborne, K. J., Nadig, A., Haase, C. M., & Mittal, V. A. (2023). Alterations in facial expressions in individuals at risk for psychosis: a facial electromyography approach using emotionally evocative film clips. Psychological Medicine, 53(12), 5829-5838.

Gupta, T., Cowan, H. R., Strauss, G. P., Walker, E. F., & Mittal, V. A. (2021). Deconstructing negative symptoms in individuals at clinical high-risk for psychosis: evidence for volitional and diminished emotionality subgroups that predict clinical presentation and functional outcome. Schizophrenia Bulletin, 47(1), 54-63.

Gupta, T., Haase, C. M., Strauss, G. P., Cohen, A. S., & Mittal, V. A. (2019). Alterations in facial expressivity in youth at clinical high-risk for psychosis. Journal of Abnormal Psychology, 128(4), 341.

Gupta, T., & Mittal, V. A. (2019). Advances in clinical staging, early intervention, and the prevention of psychosis. F1000Research, 8.

 

 

Back to Top